Biotron Limited (ASX:BIT)
Australia · Delayed Price · Currency is AUD 0.0030
0.00 (0.00%)
Sep 25, 2025, 9:59 AM AEST
Biotron Market Cap
Biotron has a market cap or net worth of 4.65 million as of September 24, 2025. Its market cap has decreased by -80.20% in one year.
Market Cap
4.65M
Enterprise Value
3.71M
Revenue
1.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since March 19, 2001, Biotron's market cap has decreased from 12.40M to 4.65M, a decrease of -62.54%. That is a compound annual growth rate of -3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 4.65M | -71.40% |
| Dec 31, 2024 | 16.24M | -81.44% |
| Dec 29, 2023 | 87.52M | 259.40% |
| Dec 30, 2022 | 24.35M | -64.23% |
| Dec 31, 2021 | 68.09M | 24.36% |
| Dec 31, 2020 | 54.75M | 50.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 96.03B |
| Pro Medicus | 32.74B |
| Cochlear | 19.18B |
| Sonic Healthcare | 11.09B |
| Ramsay Health Care | 7.58B |
| Telix Pharmaceuticals | 4.92B |
| Ansell | 4.90B |
| Mesoblast | 3.08B |